Pfizer refuses to withdraw heart risk painkiller

US drugs giant Pfizer admitted it had found an increased risk of heart attacks with patients taking its top-selling painkiller Celebrex – but has no plans to remove it from the market.

Pfizer announced yesterday that it found the increased risk in one of two long-term cancer prevention trials, while the other trial showed no increased risk.